Journal of Clinical Epidemiology
Volume 52, Issue 12 , Pages 1131-1136 , December 1999

Serious Co-morbidity Among Unselected Cancer Patients Newly Diagnosed in the Southeastern Part of The Netherlands in 1993–1996

  • J.W.W Coebergh

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Center South (IKZ), Eindhoven, The Netherlands
    • Department of Epidemiology & Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands
    • Corresponding Author InformationAddress for correspondence: J. W. W. Coebergh, IKZ, P.O. Box 231, 5600 AE Eindhoven, The Netherlands.
    • ,
  • M.L.G Janssen-Heijnen

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Center South (IKZ), Eindhoven, The Netherlands
    • ,
  • P.N Post

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Center South (IKZ), Eindhoven, The Netherlands
    • Department of Epidemiology & Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands
    • ,
  • P.P.A Razenberg

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Center South (IKZ), Eindhoven, The Netherlands

,Accepted 20 April 1999.

References 

  1. de Rijke JM, Schouten LJ, Schouten HC, Jager JJ, Koppejan AG, van den Brandt PA. Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the Netherlands. Ann Oncol. 1996;7:677–685
  2. Exterman M, Overcash J, Lyman GH, Parr J, Balducci L. Co-morbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16:1582–1587
  3. Feinstein AR. The pretherapeutic classification of chronic disease. J Chron Dis. 1970;23:455–468
  4. Piccirillo JF, Feinstein AR. Clinical symptoms and co-morbidity (Significance for the prognostic classification of cancer). Cancer. 1996;77:834–842
  5. Feinstein AR. On classifying cancers while treating patients. Arch Int Med. 1985;145:1789–1791
  6. Satariano WA, Ragland DR. The effect of co-morbidity on 3 year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104–110
  7. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co-morbidity on life-expectancy among men with localized prostate cancer. J Urol. 1996;156:127–132
  8. Coebergh JWW, Janssen-Heijnen MLG, Razenberg PPA. Prevalence of co-morbidity in newly diagnosed patients with cancer: A population-based study. Crit Rev Oncol Hematol 1998: 27: 97–100.
  9. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies (Development and validation). J Chron Dis. 1987;40:373–383
  10. In:  Coebergh JWW,  van der Heijden LH,  Janssen-Heijnen MLG editor. Cancer Incidence and Survival in the Southeast of The Netherlands 1955–1994; a report from the Eindhoven Cancer Registry. Eindhoven: Integraal Kankercentrum Zuid; 1995;
  11. Janssen-Heijnen MLG, Coebergh JWW, Razenberg PPA. Validation study of co-morbidity in lung cancer patients diagnosed in 1995. Eindhoven Cancer Registry, Internal report; 1997.
  12. Janssen-Heijnen MLG, Coebergh JWW, Razenberg PPA. Validation study of co-morbidity in patients with endometrial carcinoma diagnosed in 1994 and 1995. Eindhoven Cancer Registry, Internal report; 1997.
  13. Post PN, Janssen-Heijnen MLG, Coebergh JWW, Razenberg PPA. Validation study of co-morbidity in prostate cancer patients diagnosed in 1995. Eindhoven Cancer Registry, Internal report; 1997.
  14. Janssen-Heijnen MLG, Schipper RM, Razenberg PPA, Crommelin MA, Coebergh JWW. Prevalence of co-morbidity in newly diagnosed patients with lung cancer, according to morphology, stage and resection rate: A registry-based study. (Lung Cancer).
  15. Serdula MK, Byers T, Mokdad AH, Simoes E, Mendlein JM, Coates RJ. The association between fruit and vegetable intake and chronic disease risk factors. Epidemiology. 1996;7:161–165
  16. Marco de MF, Janssen-Heijnen MLG, Heijden LH van der, Coebergh JWW. Co-morbidity and colorectal cancer according to subsite and stage: A population-based study. Eur J Cancer (in press).
  17. Okkes IM, Lamberts H. Different figures for frequencies of diseases in health surveys and morbidity in general practice (in Dutch). Ned Tijdschr Geneeskd. 1997;141:207–219
  18. Boice JD, Curtis RE, Kleinerman RA, Storm HH, Jensen OM, Jensen HS, et al. Multiple primary cancers in Connecticut and Denmark. NIH Publication No. 85-2714. Bethesda: National Cancer Institute; 1985;
  19. Yancik R, Havlik RJ, Wesley MN, Ries L, Long S, Rossi WK, et al. Cancer and co-morbidity in older patients (A descriptive profile). Ann Epidemiol. 1996;6:399–412
  20. Pedersen T, Eliasen K, Henriksen E. A prospective study of mortality associated with anaesthesia and surgery (Risk indicators of mortality in hospital). Acta Anaesthesiol Scand. 1990;343:176–182
  21. Fowkes FGR, Lunn JN, Farrow SC, Robertson IB, Samuel P. Epidemiology in anaesthesia. III (Mortality risk in patients with coexisting physical disease). Br J Anaesth. 1982;54:819–825
  22. Schrijvers CTM, Coebergh JWW, Mackenbach JP. Socioeconomic status and co-morbidity among newly diagnosed cancer patients. Cancer. 1997;80:1482–1488
  23. Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst. 1996;88:1031–1038
  24. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol. 1997;50:693–703
  25. Pasulka PS, Bistrian BR, Benotti PN, Blackburn GL. The risks of surgery in obese patients. Ann Intern Med. 1986;104:540–546
  26. Monfardini S, Ferrucci L, Fratino L, Del Lungo I, Serraino D, Zagonel V. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer. 1996;77:395–401

PII: S0895-4356(99)00098-0

Journal of Clinical Epidemiology
Volume 52, Issue 12 , Pages 1131-1136 , December 1999

Article Tools